Gonna be up early lol, prolly beat the roosters 🐔
Recent TIVC News
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 04/20/2026 08:10:20 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/16/2026 04:15:25 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/15/2026 09:10:33 PM
- Tivic Health Selected to Present Entolimod™ as a Radiation Countermeasure and its Plans for an Oral Transmucosal Program to the Department of War Tech Watch Program on May 7th • PR Newswire (US) • 04/15/2026 12:00:00 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 04/13/2026 09:11:45 PM
- Tivic Receives Formal Request for Information from Ukrainian Ministry of Health Regarding Strategic Stockpiling of Entolimod • ACCESS Newswire • 03/31/2026 12:30:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/30/2026 09:34:51 PM
- Tivic CEO To Present at the Upcoming Emerging Growth's April 2026 Virtual Conference • ACCESS Newswire • 03/27/2026 03:30:00 PM
- Tivic Secures NIAID Non-Clinical Evaluation Agreement for Entolimod, Targeting Gastrointestinal Acute Radiation Syndrome • ACCESS Newswire • 03/26/2026 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/25/2026 08:25:57 PM
- Tivic Reports Full Year 2025 Results • ACCESS Newswire • 03/25/2026 08:05:00 PM
- Tivic Health CEO Letter to Shareholders • ACCESS Newswire • 03/24/2026 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/20/2026 09:15:08 PM
- Tivic To Report 2025 Year-End Financial Results Via Conference Call and Webcast on March 25th at 1:30pm PT / 4:30pm ET • ACCESS Newswire • 03/20/2026 07:35:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/20/2026 01:14:41 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/13/2026 09:27:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/04/2026 01:30:42 PM
- Biotech Veteran Michael K. Handley Named CEO of Tivic Health Systems to Spearhead Strategic Expansion in Biopharma • ACCESS Newswire • 03/04/2026 01:30:00 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 02/27/2026 09:05:24 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 02/23/2026 10:15:11 PM
- Tivic and BARDA Continue Discussions of Entolimod for Acute Radiation Syndrome on March 10 • ACCESS Newswire • 02/18/2026 02:15:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 02/09/2026 09:46:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/09/2026 09:45:28 PM
- Tivic, BARDA Discuss Entolimod(TM) for Acute Radiation Syndrome at TechWatch Meeting • ACCESS Newswire • 01/28/2026 01:30:00 PM
- Tivic to Showcase Strategic Pivot and Forward Outlook on Advancing Entolimod(TM) to Commercialization at DealFlow Discovery Conference • ACCESS Newswire • 01/26/2026 03:10:00 PM
